KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Payables (2016 - 2025)

Historic Payables for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $315.3 million.

  • Zimmer Biomet Holdings' Payables fell 220.22% to $315.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $315.3 million, marking a year-over-year decrease of 220.22%. This contributed to the annual value of $194.6 million for FY2024, which is 5260.59% down from last year.
  • Zimmer Biomet Holdings' Payables amounted to $315.3 million in Q3 2025, which was down 220.22% from $348.7 million recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Payables ranged from a high of $437.1 million in Q4 2022 and a low of $194.6 million during Q4 2024
  • Its 5-year average for Payables is $336.9 million, with a median of $329.8 million in 2021.
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 4261.01% in 2022, then tumbled by 5260.59% in 2024.
  • Over the past 5 years, Zimmer Biomet Holdings' Payables (Quarter) stood at $306.5 million in 2021, then surged by 42.61% to $437.1 million in 2022, then decreased by 6.06% to $410.6 million in 2023, then crashed by 52.61% to $194.6 million in 2024, then skyrocketed by 62.02% to $315.3 million in 2025.
  • Its Payables was $315.3 million in Q3 2025, compared to $348.7 million in Q2 2025 and $301.3 million in Q1 2025.